Philip I Song, MD
Dermatology · Antioch
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Song’s office at (925) 779-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A161047 · Current
Licensed to practise in California · since 2019 · expires 2027-03-31 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$319,871
Pharmacies billed $319,871 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 565) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
468 generic and 97 brand-name prescriptions · $319,871 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Otezla | 36 | $159,602 | $4,433 |
| Dupixent | 14 | $54,930 | $3,924 |
| Amjevita(Cf) | 12 | $11,570 | $964 |
| Clobetasol Propionate | 128 | $4,034 | $32 |
| Tacrolimus | 30 | $3,211 | $107 |
See all 13 drugs
| Otezla | 36 | $159,602 | $4,433 |
| Dupixent | 14 | $54,930 | $3,924 |
| Amjevita(Cf) | 12 | $11,570 | $964 |
| Clobetasol Propionate | 128 | $4,034 | $32 |
| Tacrolimus | 30 | $3,211 | $107 |
| Fluorouracil | 35 | $1,404 | $40 |
| Ketoconazole | 53 | $768 | $14 |
| Triamcinolone Acetonide | 32 | $711 | $22 |
| Hydrocortisone | 32 | $527 | $16 |
| Fluocinolone Acetonide | 12 | $330 | $27 |
| Clindamycin Phosphate | 12 | $261 | $22 |
| Terbinafine | 13 | $138 | $11 |
| Mupirocin | 13 | $132 | $10 |
Year by year
| 2024 | 565 | 203 | 0% (0) | 17% | $319,871 |
| 2023 | 675 | 265 | 0% (0) | 12% | $310,086 |
| 2022 | 566 | 211 | 0% (0) | 8% | $79,345 |
| 2021 | 421 | 194 | 0% (0) | 5% | $48,084 |
| 2020 | 416 | 163 | 0% (0) | 6% | $60,071 |
| 2019 | 322 | 130 | 0% (0) | 18% | $58,092 |
| 2018 | 265 | 107 | 0% (0) | 24% | $26,535 |
| 2017 | 164 | 74 | 0% (0) | 20% | $13,805 |
| 2016 | 108 | 55 | 0% (0) | 24% | $9,236 |
| 2015 | 130 | 48 | None | None | $6,973 |
| 2014 | 212 | 55 | None | 9% | $17,230 |
| 2013 | 210 | 49 | None | 10% | $19,891 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Otezla | 31 | $132,289 | $4,267 |
| Clobetasol Propionate | 110 | $3,977 | $36 |
| Tacrolimus | 28 | $3,420 | $122 |
| Acitretin | 18 | $2,521 | $140 |
| Fluorouracil | 53 | $2,424 | $46 |
| Triamcinolone Acetonide | 56 | $1,342 | $24 |
| Fluocinonide | 22 | $1,077 | $49 |
| Ketoconazole | 68 | $1,006 | $15 |
| Hydrocortisone | 42 | $704 | $17 |
| Mupirocin | 35 | $606 | $17 |
| Retin-A | 11 | $554 | $50 |
| Doxycycline Monohydrate | 17 | $427 | $25 |
| Methotrexate | 13 | $181 | $14 |
2022: 14 drugs
| Clobetasol Propionate | 124 | $8,610 | $69 |
| Tacrolimus | 23 | $3,885 | $169 |
| Fluorouracil | 51 | $3,024 | $59 |
| Acitretin | 19 | $2,188 | $115 |
| Triamcinolone Acetonide | 65 | $1,642 | $25 |
| Betamethasone Diprop Augmented | 14 | $1,177 | $84 |
| Fluocinonide | 14 | $976 | $70 |
| Retin-A | 12 | $828 | $69 |
| Ketoconazole | 41 | $672 | $16 |
| Doxycycline Monohydrate | 18 | $462 | $26 |
| Mupirocin | 26 | $453 | $17 |
| Hydrocortisone | 25 | $377 | $15 |
| Clindamycin Phosphate | 14 | $360 | $26 |
| Methotrexate | 16 | $200 | $12 |
2021: 11 drugs
| Clobetasol Propionate | 110 | $8,666 | $79 |
| Tacrolimus | 15 | $2,764 | $184 |
| Betamethasone Diprop Augmented | 20 | $1,761 | $88 |
| Fluorouracil | 22 | $1,318 | $60 |
| Triamcinolone Acetonide | 39 | $976 | $25 |
| Fluocinonide | 11 | $936 | $85 |
| Ketoconazole | 26 | $572 | $22 |
| Hydrocortisone | 27 | $462 | $17 |
| Prednisone | 21 | $278 | $13 |
| Mupirocin | 16 | $238 | $15 |
| Methotrexate | 12 | $147 | $12 |
2020: 10 drugs
| Clobetasol Propionate | 77 | $5,743 | $75 |
| Betamethasone Dipropionate | 26 | $3,337 | $128 |
| Ketoconazole | 59 | $1,812 | $31 |
| Fluorouracil | 20 | $1,353 | $68 |
| Betamethasone Diprop Augmented | 16 | $1,292 | $81 |
| Fluocinonide | 14 | $827 | $59 |
| Hydroxychloroquine Sulfate | 12 | $608 | $51 |
| Triamcinolone Acetonide | 27 | $314 | $12 |
| Mupirocin | 27 | $314 | $12 |
| Hydrocortisone | 21 | $172 | $8 |
2019: 7 drugs
| Betamethasone Diprop Augmented | 26 | $4,492 | $173 |
| Betamethasone Dipropionate | 33 | $3,356 | $102 |
| Clobetasol Propionate | 29 | $3,162 | $109 |
| Halobetasol Propionate | 11 | $1,319 | $120 |
| Ketoconazole | 43 | $1,260 | $29 |
| Triamcinolone Acetonide | 26 | $325 | $12 |
| Hydrocortisone | 19 | $129 | $7 |
2018: 8 drugs
| Betamethasone Diprop Augmented | 19 | $3,408 | $179 |
| Betamethasone Dipropionate | 27 | $2,974 | $110 |
| Fluocinolone Acetonide | 11 | $2,241 | $204 |
| Ketoconazole | 40 | $1,637 | $41 |
| Metronidazole | 15 | $1,418 | $95 |
| Methotrexate | 12 | $1,033 | $86 |
| Triamcinolone Acetonide | 32 | $464 | $14 |
| Hydrocortisone | 14 | $129 | $9 |
2017: 4 drugs
| Betamethasone Dipropionate | 18 | $1,701 | $94 |
| Ketoconazole | 21 | $1,647 | $78 |
| Betamethasone Dipropionate | 16 | $1,586 | $99 |
| Triamcinolone Acetonide | 24 | $352 | $15 |
2016: 2 drugs
| Tretinoin | 11 | $2,171 | $197 |
| Betamethasone Dipropionate | 12 | $544 | $45 |
2015: 1 drug
| Ranitidine | 18 | $168 | $9 |
2014: 1 drug
| Omeprazole | 15 | $308 | $21 |
2013: 2 drugs
| Simvastatin | 12 | $129 | $11 |
| Glipizide | 14 | $89 | $6 |
Money from drug and device companies
$24 in 2025
| 2025 | 1 | 1 | None | $24 |
| 2024 | 1 | 1 | None | $22 |
| 2023 | 1 | 4 | None | $85 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Perclose Prostyle | $24 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2025-08-26 | Perclose Prostyle | $24 |
See earlier years (2024, 2023)
2024: $22
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $22 | 1 payment
|
2023: $85
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $85 | 4 payments
|
Professional record
- NPI
- 1083859888
- Licence
- CA A161047California A161047: Current · expires 2027-03-31
- Trained
- Johns Hopkins University School of Medicine, 2011
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 3201 Danville Blvd Ste 110, Alamo, CA, 94507
- NPI first listed
- 2008-12-08
- NPI last updated
- 2026-09-01
- NPI record certified
- 2026-09-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 401 Old San Francisco Rd, Sunnyvale, CA, 94086
This office lists an electronic records connection.